Covered recipient · General Payments record
ANNA MATHEW
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2019
$3,240.34
- Reported across 161 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2019 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $920.54 | 56 |
| Gift | $427.00 | 1 |
By paying entity
PY2019 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Tosoh Bioscience, Inc. | $427.00 | 1 |
| Janssen Biotech, Inc. | $91.70 | 7 |
| Genentech USA, Inc. | $74.30 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $71.63 | 4 |
| Merck Sharp & Dohme Corporation | $63.18 | 4 |
| PFIZER INC. | $60.15 | 4 |
| Amgen Inc. | $55.55 | 2 |
| EISAI INC. | $51.10 | 3 |
| GENZYME CORPORATION | $49.00 | 3 |
| Pharmacyclics LLC, An AbbVie Company | $40.60 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $39.85 | 2 |
| ABBVIE INC. | $37.63 | 2 |
| Janssen Pharmaceuticals, Inc | $35.96 | 3 |
| Gilead Sciences, Inc. | $32.40 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $29.19 | 2 |
| Acerta Pharma LLC | $24.62 | 2 |
| Lilly USA, LLC | $23.71 | 1 |
| Regeneron Healthcare Solutions, Inc. | $23.18 | 1 |
| E.R. Squibb & Sons, L.L.C. | $17.37 | 1 |
| PORTOLA PHARMACEUTICALS, INC. | $16.69 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.90 | 1 |
| Rigel Pharmaceuticals, Inc. | $15.36 | 1 |
| Helsinn Therapeutics (U.S.), Inc. | $15.28 | 1 |
| SEAGEN INC. | $13.32 | 1 |
| Ipsen Biopharmaceuticals, Inc | $11.64 | 1 |
| EMD Serono, Inc. | $11.23 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2019 (57)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019
- Source files
- Dataset page · Bulk file · PY2018 , PY2019
- Generated from
- OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.